272 related articles for article (PubMed ID: 11457647)
1. SB203580, a specific inhibitor of p38-MAPK pathway, is a new reversal agent of P-glycoprotein-mediated multidrug resistance.
Barancík M; Bohácová V; Kvackajová J; Hudecová S; Krizanová O; Breier A
Eur J Pharm Sci; 2001 Aug; 14(1):29-36. PubMed ID: 11457647
[TBL] [Abstract][Full Text] [Related]
2. Increased p38-MAPK is responsible for chemotherapy resistance in human gastric cancer cells.
Guo X; Ma N; Wang J; Song J; Bu X; Cheng Y; Sun K; Xiong H; Jiang G; Zhang B; Wu M; Wei L
BMC Cancer; 2008 Dec; 8():375. PubMed ID: 19091131
[TBL] [Abstract][Full Text] [Related]
3. LY294,002, a specific inhibitor of PI3K/Akt kinase pathway, antagonizes P-glycoprotein-mediated multidrug resistance.
Barancík M; Bohácová V; Sedlák J; Sulová Z; Breier A
Eur J Pharm Sci; 2006 Dec; 29(5):426-34. PubMed ID: 17010577
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of regulatory proteins in L1210/VCR cells with multidrug resistance mediated by P-glycoprotein.
Barancík M; Bohácová V; Zbýnovcová M; Breier A
Gen Physiol Biophys; 1999 Mar; 18(1):45-56. PubMed ID: 10378120
[TBL] [Abstract][Full Text] [Related]
5. Multidrug resistant P-glycoprotein positive L1210/VCR cells are also cross-resistant to cisplatin via a mechanism distinct from P-glycoprotein-mediated drug efflux activity.
Gibalová L; Sedlák J; Labudová M; Barancík M; Reháková A; Breier A; Sulová Z
Gen Physiol Biophys; 2009 Dec; 28(4):391-403. PubMed ID: 20097962
[TBL] [Abstract][Full Text] [Related]
6. Reversal of P-glycoprotein mediated vincristine resistance of L1210/VCR cells by analogues of pentoxifylline. A QSAR study.
Kupsáková I; Rybár A; Docolomanský P; Drobná Z; Stein U; Walther W; Barancík M; Breier A
Eur J Pharm Sci; 2004 Feb; 21(2-3):283-93. PubMed ID: 14757500
[TBL] [Abstract][Full Text] [Related]
7. Direct interaction between verapamil and doxorubicin causes the lack of reversal effect of verapamil on P-glycoprotein mediated resistance to doxorubicin in vitro using L1210/VCR cells.
Breier A; Drobná Z; Barancík M
Neoplasma; 1998; 45(4):248-53. PubMed ID: 9890669
[TBL] [Abstract][Full Text] [Related]
8. Time dependence of [3H]-vincristine accumulation by L1210 mouse leukemic cells. Effect of P-glycoprotein overexpression.
Breier A; Stefanková Z; Barancík M; Tribulová N
Gen Physiol Biophys; 1994 Aug; 13(4):287-98. PubMed ID: 7890145
[TBL] [Abstract][Full Text] [Related]
9. Reversal of MRP-mediated vincristine resistance in KB cells by buthionine sulfoximine in combination with PAK-104P.
Chuman Y; Chen ZS; Seto K; Sumizawa T; Furukawa T; Tani A; Haraguchi M; Niwa K; Yamada K; Aikou T; Akiyama S
Cancer Lett; 1998 Jul; 129(1):69-76. PubMed ID: 9714337
[TBL] [Abstract][Full Text] [Related]
10. Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity.
Sulová Z; Macejová D; Seres M; Sedlák J; Brtko J; Breier A
Toxicol In Vitro; 2008 Feb; 22(1):96-105. PubMed ID: 17920233
[TBL] [Abstract][Full Text] [Related]
11. Reversal effect of specific inhibitors of extracellular-signal regulated protein kinase pathway on P-glycoprotein mediated vincristine resistance of L1210 cells.
Kisucká J; Barancík M; Bohácová V; Breier A
Gen Physiol Biophys; 2001 Dec; 20(4):439-44. PubMed ID: 11989653
[TBL] [Abstract][Full Text] [Related]
12. Pyramidatine (Z88) Sensitizes Vincristine-Resistant Human Oral Cancer (KB/VCR) Cells to Chemotherapeutic Agents by Inhibition of P-glycoprotein.
Liu Z; Zhu H; Qu S; Tang L; Cao L; Yu W; Yang X; Jiang S; Zhu D; Tan C; Yu L
Anticancer Agents Med Chem; 2018; 18(2):286-294. PubMed ID: 28782465
[TBL] [Abstract][Full Text] [Related]
13. Potentiation of anticancer drugs: effects of pentoxifylline on neoplastic cells.
Barancik M; Bohacova V; Gibalova L; Sedlak J; Sulova Z; Breier A
Int J Mol Sci; 2012; 13(1):369-82. PubMed ID: 22312258
[TBL] [Abstract][Full Text] [Related]
14. P-glycoprotein-mediated multidrug resistance phenotype of L1210/VCR cells is associated with decreases of oligo- and/or polysaccharide contents.
Fiala R; Sulová Z; El-Saggan AH; Uhrík B; Liptaj T; Dovinová I; Hanusovská E; Drobná Z; Barancík M; Breier A
Biochim Biophys Acta; 2003 Nov; 1639(3):213-24. PubMed ID: 14636953
[TBL] [Abstract][Full Text] [Related]
15. Reversal of P-glycoprotein-mediated multidrug resistance in SGC7901/VCR cells by PPARgamma activation by troglitazone.
Chen Q; Zhou J; Jiang C; Chen J
J Huazhong Univ Sci Technolog Med Sci; 2010 Jun; 30(3):326-31. PubMed ID: 20556576
[TBL] [Abstract][Full Text] [Related]
16. Effect of pentoxifylline on P-glycoprotein mediated vincristine resistance of L1210 mouse leukemic cell line.
Breier A; Barancík M; Stefanková Z; Uhrík B; Tribulová N
Neoplasma; 1994; 41(5):297-303. PubMed ID: 7854500
[TBL] [Abstract][Full Text] [Related]
17. Modulation of phorbol ester-induced regulation of matrix metalloproteinases and tissue inhibitors of metalloproteinases by SB203580, a specific inhibitor of p38 mitogen-activated protein kinase.
Park MJ; Park IC; Hur JH; Kim MS; Lee HC; Woo SH; Lee KH; Rhee CH; Hong SI; Lee SH
J Neurosurg; 2002 Jul; 97(1):112-8. PubMed ID: 12134900
[TBL] [Abstract][Full Text] [Related]
18. L1210 cells cultivated under the selection pressure of doxorubicin or vincristine express common mechanisms of multidrug resistance based on the overexpression of P-glycoprotein.
Bohácová V; Sulová Z; Dovinová I; Poláková E; Barancík M; Uhrík B; Orlický J; Breier A
Toxicol In Vitro; 2006 Dec; 20(8):1560-8. PubMed ID: 16962737
[TBL] [Abstract][Full Text] [Related]
19. Effect of mitogen-activated protein kinase signal transduction pathway on multidrug resistance induced by vincristine in gastric cancer cell line MGC803.
Chen B; Jin F; Lu P; Lu XL; Wang PP; Liu YP; Yao F; Wang SB
World J Gastroenterol; 2004 Mar; 10(6):795-9. PubMed ID: 15040019
[TBL] [Abstract][Full Text] [Related]
20. The p38 MAP kinase inhibitor SB203580 enhances nuclear factor-kappa B transcriptional activity by a non-specific effect upon the ERK pathway.
Birkenkamp KU; Tuyt LM; Lummen C; Wierenga AT; Kruijer W; Vellenga E
Br J Pharmacol; 2000 Sep; 131(1):99-107. PubMed ID: 10960075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
